ReviewJournal of virology2026
Alphavirus replicase and regulatory RNA elements in host interactions and viral vector engineering.
Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alphavirus-derived vector systems have been used for heterologous gene expression for nearly four decades, providing foundational insights into RNA virus replication, host interactions, and genome engineering. The recent success of conventional mRNA vaccines has intensified interest in leveraging the alphavirus replicase and its associated conserved sequence elements (CSEs) to develop self-amplifying mRNA (sa-mRNA) platforms characterized by more sustained antigen expression and dose-sparing. In this minireview, we summarize key advances that define the coordinated functions of the nonstructural proteins and CSEs in viral RNA synthesis and host modulation. We then contextualize the developmental milestones of alphavirus replicons that underpin modern sa-mRNA technologies. We further discuss emerging strategies to engineer replicase functions and RNA architecture in different sa-mRNA applications, while outlining critical gaps in alphavirus biology that currently constrain rational sa-mRNA design. Renewed investigation of nonstructural proteins and CSEs will accelerate optimization of next-generation sa-mRNA platforms and reinvigorate fundamental studies of alphavirus replication, evolution, and host adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.